Abstract
The findings of the meta-analysis about the comparative efficacy of drug-eluting stents (DESs) compared with bare-metal stents (BMSs) by Nordmann et al .1 both re-affirm and enhance those observed in previous research. Katritsis et al .2 have also demonstrated the lack of any efficacy superiority of DES over BMS, during the relatively short-term follow-up of between six and 12 months from intervention. Unsurprisingly for a health intervention with questionable clinical efficacy, the cost-effectiveness ratios of the current practice of nearly routine use …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
